Biogen is going nuts. They are throwing 45 million smackeroos at a Phase 1 trial for a -- you guessed it -- anti-Tau drug. And they're doubling down on their failed bet on the amyloid drug.

https://www.fiercebiotech.com/biotech/biogen-...d=48083647